Role of Goal Directed Fluid Therapy in Enhanced Recovery After Surgery in

Status Completed

Clinical Trial Summary

Enhanced recovery after surgery (ERAS) protocols are multimodal perioperative care pathways designed to achieve early recovery and reducing postoperative morbidity after surgical procedures by maintaining preoperative organ function and reducing the profound stress response following surgery .The key elements of ERAS protocols include preoperative counselling, optimization of nutrition, standardized analgesic and anesthetic regimens , goal directed fluid therapy early mobilization.

Clinical Trial Description

For the proposed study investigators plan to include total 60 patients with 30 each allotted to GDFT(SVV) and CVP Group ,belonging to ASA ( American Society of Anesthesiology)Grade I/II/III, study will be conducted after obtaining written informed consent from all patients and approval from the scientific committee and Institutional Review Board (IRB). All patients will receive one-third starvation fluid as crystalloid during first hour of surgery . Night prior to and on the day of surgery carbo load will be given to all patients according to the protocol.Monitoring included 5 lead ECG SPO2,ETCO2, Invasive Blood Pressure (IBP - Radial),CVP(site IJV),core Temperature . Standard General anaesthesia with oral Endotracheal tube and Intermittent Positive Pressure Ventilation will be given to all patients.Patients will be allotted randomly to either Goal Directed Fluid Therapy (GDFT) /SVV - Stroke Volume Variation or Conventional Central Venous Pressure - CVP guided fluid Therapy Group. During the surgery - Heart rate , Mean arterial Blood Pressure , Urine output , Blood loss , Seum lactate levels will be noted. For SVV Group - SVV , Stroke Volume Index (SVI) , Systemic vascular resistance index (SVRI) ,Cardiac Index (CI) values will be noted every 30 minutes- the goal is to maintain SVV value >11 and to give colloid bolus 200ml whenever SVV values rise above11.Pre and post bolus SVV, SV, SVI and SVRI shall be recorded. For CVP Group - Goal is to maintain CVP values between 8-12 cmsH20 and for decrease in value < 8 colloid bolus of 200ml will be given and change in CVP value will be noted. Patients in both the groups will receive Noradrenaline infusion if MAP <70 mmHg with optimal fluid transfusion .Target for transfusing Packed red blood cells will be value of haematocrit < 24 Postoperative HR, MAP, I/O-charting, Serum Creatinine, Serum Lactate, bowel sounds, Inotrope requirement, Visual Analogue Score, Ryles Tube Feeds, Epidural analgesia ,Length of stay (hours in SICU) and any postoperative complications shall be noted. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06026475
Study type	Interventional
Source	Rajiv Gandhi Cancer Institute & Research Center, India
Contact
Status	Completed
Phase	N/A
Start date	July 13, 2023
Completion date	January 30, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05070819` - Atrial Natriuretic Peptide in Assessing Fluid Status	N/A
Completed	`NCT05012462` - Clinical Evaluation of the CM-1500 During Apheresis Blood Donation	N/A
Completed	`NCT05463198` - Evaluation of Physiological Variables and Detection of Blood Loss Using the Zynex Fluid Monitoring System, Model CM-1600	N/A
Completed	`NCT06097923` - Implementation of Fluid Strategies Using Real-time Bioelectrical Analyzer in Surgical Intensive Care Unit (SICU)	N/A
Completed	`NCT05125848` - Clinical Evaluation of the CM-1500 During Hemodialysis	N/A
Completed	`NCT03133767` - Saline vs. Lactated Ringers for Emergency Department IV Fluid Resuscitation	Phase 4
Recruiting	`NCT05705115` - Acetated Ringer´s Solution in Experimental Hypovolemia	Phase 4
Completed	`NCT03204292` - Evaluating the Fluid Balance of Mechanically Ventilated Patients by Ultrasonography	N/A
Completed	`NCT02052284` - The Application of Sterile Water to the Skin of Extremely Low Birth Weight (ELBW) Infants	N/A
Enrolling by invitation	`NCT05278013` - Utility of 2- Octyl Cyanoacrylate (2-OCA)	N/A
Completed	`NCT06101498` - Peroperative Fluid Management in Major Gynecological Cancer Surgeries	N/A
Terminated	`NCT01788293` - Fluid Management Based on Pleth Variability Index (PVI) Monitoring During High-risk Surgery	N/A
Completed	`NCT05740644` - Clinical Evaluation of the Zynex Monitoring System, Model CM-1600	N/A
Completed	`NCT04598386` - The Effect of AMP Human Sodium Bicarbonate Lotion on Hydration	N/A
Completed	`NCT05980013` - Evaluation of Physiological Variables and Detection of Blood Loss in Healthy Adults With Different Subject Positioning by the CM-1500	N/A
Completed	`NCT05968105` - Changes in Vessels After Peripheral Block
Recruiting	`NCT03552601` - The Effect of Negatively Fluid Balancing Speed for ICU Patients With Acute Respiratory Distress Syndrome	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Role of Goal Directed Fluid Therapy in Enhanced Recovery After Surgery in Gastro-intestinal Oncosurgeries — GDFT ERAS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms